Sundrug Co.,Ltd. (TYO:9989)

Sundrug Balance Sheet

Financials in millions JPY. Fiscal year is April - March.

Assets

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Cash & Equivalents	61,353	70,523	64,956	69,698	80,872	89,330
Cash & Short-Term Investments	61,353	70,523	64,956	69,698	80,872	89,330
Cash Growth	-2.58%	8.57%	-6.80%	-13.82%	-9.47%	3.28%
Accounts Receivable	29,575	32,330	29,994	26,740	22,219	19,104
Other Receivables	-	19,166	18,390	15,900	15,284	14,352
Receivables	29,575	51,496	48,384	42,640	37,503	33,456
Inventory	112,669	110,322	98,674	91,292	83,027	72,541
Other Current Assets	21,543	5,723	4,763	4,613	4,505	4,210
Total Current Assets	225,140	238,064	216,777	208,243	205,907	199,537
Property, Plant & Equipment	151,803	148,487	136,706	120,536	100,248	77,855
Long-Term Investments	32,427	63,956	64,653	65,688	29,428	27,425
Goodwill	1,296	1,325	1,440	1,556	1,671	2
Other Intangible Assets	6,607	6,776	7,229	7,587	7,433	5,952
Long-Term Deferred Tax Assets	-	9,942	9,836	8,951	7,978	7,291
Other Long-Term Assets	48,013	2	2	2	2	2
Total Assets	465,286	475,505	444,007	420,208	360,672	325,768

Liabilities

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Accounts Payable	77,637	82,707	79,731	77,371	74,006	67,029
Short-Term Debt	-	1,000	1,000	35,000	-	-
Current Portion of Long-Term Debt	5,191	5,139	3,800	-	-	-
Current Income Taxes Payable	4,334	8,504	8,180	7,547	8,249	5,199
Other Current Liabilities	35,596	36,685	35,796	35,548	30,994	23,817
Total Current Liabilities	122,802	134,035	128,507	155,466	113,249	96,045
Long-Term Debt	42,774	42,076	33,866	-	-	-
Pension & Post-Retirement Benefits	2,562	2,504	2,383	2,473	2,296	1,696
Other Long-Term Liabilities	10,876	10,889	9,537	9,179	8,799	7,435
Total Liabilities	179,014	189,504	174,293	167,118	124,344	105,176

Shareholders' Equity

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Common Stock	3,931	3,931	3,931	3,931	3,931	3,931
Additional Paid-In Capital	7,577	7,577	7,533	7,496	7,430	7,430
Retained Earnings	280,155	279,859	263,754	247,272	230,658	215,145
Treasury Stock	-3,843	-3,843	-3,868	-3,894	-3,940	-3,939
Comprehensive Income & Other	-1,548	-1,523	-1,636	-1,715	-1,751	-1,975
Shareholders' Equity	286,272	286,001	269,714	253,090	236,328	220,592
Total Liabilities & Equity	465,286	475,505	444,007	420,208	360,672	325,768

Additional Metrics

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Total Debt	47,965	48,215	38,666	35,000	-	-
Net Cash (Debt)	13,388	22,308	26,290	34,698	80,872	89,330
Net Cash Growth	-28.65%	-15.15%	-24.23%	-57.09%	-9.47%	3.28%
Net Cash Per Share	114.44	190.70	224.77	296.71	691.62	764.00
Filing Date Shares Outstanding	116.98	116.98	116.97	116.95	116.92	116.92
Total Common Shares Outstanding	116.98	116.98	116.97	116.95	116.92	116.92
Working Capital	102,338	104,029	88,270	52,777	92,658	103,492
Book Value Per Share	2447.13	2444.81	2305.89	2164.06	2021.22	1886.64
Tangible Book Value	278,369	277,900	261,045	243,947	227,224	214,638
Tangible Book Value Per Share	2379.57	2375.56	2231.78	2085.88	1943.36	1835.71

Data Source: S&P Global Market Intelligence Last updated: Jun 30, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Aug 20, 2026

Data Sources Report a data error